Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges

Recent advances in the understanding of the biological basis of pediatric soft-tissue and bone tumors, especially owing to the advent of "omics" technologies, have led to an exponential increase in the current knowledge on the genetic and cellular patho-mechanisms that drive these diseases...

Full description

Saved in:
Bibliographic Details
Main Author: Simone Fulda (auth)
Other Authors: Thomas G. P. Grunewald (auth)
Format: Book Chapter
Published: Frontiers Media SA 2016
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 03275naaaa2200361uu 4500
001 doab_20_500_12854_42243
005 20210211
020 |a 978-2-88919-819-1 
020 |a 9782889198191 
024 7 |a 10.3389/978-2-88919-819-1  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a Simone Fulda  |4 auth 
700 1 |a Thomas G. P. Grunewald  |4 auth 
245 1 0 |a Biology-Driven Targeted Therapy of Pediatric Soft-Tissue and Bone Tumors: Current Opportunities and Future Challenges 
260 |b Frontiers Media SA  |c 2016 
300 |a 1 electronic resource (147 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a Recent advances in the understanding of the biological basis of pediatric soft-tissue and bone tumors, especially owing to the advent of "omics" technologies, have led to an exponential increase in the current knowledge on the genetic and cellular patho-mechanisms that drive these diseases. This offers the unprecedented opportunity to develop and implement targeted therapies such as monoclonal antibodies, small molecules, oncolytic viruses, and immunotherapies in standard and/or personalized treatment regimens. However, to date only a few examples document a successful translation of discoveries from the bench to the bedside. Recent international expert congresses such as the "Pediatric Cancer Translational Genomics" conference (Phoenix, Arizona, 2012), the ESF-EMBO workshop on "Molecular Biology and Innovative Therapies in Sarcomas" (Pultusk, Poland, 2012), and the AACR special meeting on "Pediatric Cancer at the Crossroads - Translating Discovery into Improved Outcomes" (San Diego, California, 2013) further emphasize the urgent need for a more rapid and especially more successful translational process. Hence, we strongly believe that a Frontiers Research Topic aiming at this aspect would fit just in time and that it would have great potential to receive numerous contributions of outstanding experts of the field. The proposed Frontiers Research Topic shall provide a platform for active and interdisciplinary discussion, summarize current state-of-the-art knowledge on all basic research and translational aspects in pediatric soft-tissue and bone tumors, and offer new perspectives of how to further promote and accelerate the translational process. We welcome high-quality original research articles, brief reports, as well as opinion, hypothesis, and review articles, and especially encourage submissions from early-career scientists. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
653 |a targeted therapy 
653 |a Translational research 
653 |a Ewing sarcoma 
653 |a Sarcoma 
653 |a pediatric oncology 
653 |a Osteosarcoma 
653 |a Immunotherapy 
653 |a bone tumor 
653 |a Rhabdomyosarcoma 
653 |a epithelioid sarcoma 
856 4 0 |a www.oapen.org  |u http://journal.frontiersin.org/researchtopic/3276/biology-driven-targeted-therapy-of-pediatric-soft-tissue-and-bone-tumors-current-opportunities-and-f  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/42243  |7 0  |z DOAB: description of the publication